A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers.
Ables JL, Israel L, Wood O, Govindarajulu U, Fremont RT, Banerjee R, Liu H, Cohen J, Wang P, Kumar K, Lu G, DeVita RJ, Garcia-Ocaña A, Murrough JW, Stewart AF.
Ables JL, et al. Among authors: lu g.
J Psychopharmacol. 2024 Sep 20:2698811241273772. doi: 10.1177/02698811241273772. Online ahead of print.
J Psychopharmacol. 2024.
PMID: 39301926